GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oscotec Inc (XKRX:039200) » Definitions » Cyclically Adjusted Price-to-FCF

Oscotec (XKRX:039200) Cyclically Adjusted Price-to-FCF : (As of Jun. 06, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Oscotec Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Oscotec Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Oscotec's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oscotec Cyclically Adjusted Price-to-FCF Chart

Oscotec Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Oscotec Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Oscotec's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Oscotec's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oscotec's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Oscotec's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Oscotec's Cyclically Adjusted Price-to-FCF falls into.


;
;

Oscotec Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Oscotec's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Oscotec's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=660.349/122.5900*122.5900
=660.349

Current CPI (Mar. 2025) = 122.5900.

Oscotec Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -44.473 100.051 -54.492
201509 -6.341 100.111 -7.765
201512 -57.772 100.220 -70.667
201603 -80.277 100.561 -97.863
201606 -233.813 100.791 -284.383
201609 171.476 101.461 207.185
201612 -177.543 101.561 -214.304
201703 -38.050 102.851 -45.353
201706 5.590 102.611 6.678
201709 -57.165 103.491 -67.715
201712 -54.755 102.991 -65.175
201803 -43.423 104.101 -51.135
201806 -2.808 104.130 -3.306
201809 -151.583 105.651 -175.887
201812 -126.877 104.351 -149.054
201903 76.600 104.491 89.868
201906 108.687 104.881 127.039
201909 -152.118 105.200 -177.263
201912 -186.469 105.121 -217.456
202003 -283.168 105.354 -329.494
202006 -322.679 105.112 -376.335
202009 229.863 106.198 265.344
202012 -385.404 105.765 -446.712
202103 -366.145 107.357 -418.097
202106 518.650 107.579 591.022
202109 -513.957 108.759 -579.316
202112 -248.436 109.676 -277.688
202203 -182.587 111.848 -200.123
202206 -278.687 114.072 -299.496
202209 -221.784 114.715 -237.008
202212 -163.547 115.179 -174.070
202303 -126.669 116.507 -133.282
202306 -191.437 117.182 -200.272
202309 -232.638 118.964 -239.730
202312 -41.803 118.837 -43.123
202403 -154.165 120.123 -157.331
202406 -167.721 120.007 -171.331
202409 -158.433 120.861 -160.699
202412 -220.773 121.135 -223.424
202503 660.349 122.590 660.349

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Oscotec  (XKRX:039200) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Oscotec Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Oscotec's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Oscotec Business Description

Industry
Traded in Other Exchanges
N/A
Address
700, Daewangpangyyo-ro, A-901, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR
Oscotec Inc is engaged in drug discovery for osteoporosis, arthritis, periodontal, dental health and cancer diseases.

Oscotec Headlines

No Headlines